Study Phase 2

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study of JNJ-39758979 in Adult Japanese Subjects with Moderate Atopic Dermatitis

Trial Information

Generic NameToreforantProduct NameTherapeutic AreaImmune System DiseasesEnrollment88% Female32.2%% WhiteN/A
Product ClassSponsor Protocol Number39758979ADM2001Data PartnerJohnson & JohnsonCondition StudiedDermatitis, AtopicMean/Median Age (Years)30.7

Supporting Documentation

  • Collected Datasets Available
  • Protocol with Amendments Available
  • Statistical Analysis Plan Available
  • Clinical Study Report Available


Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.